Viking Therapeutics, Inc. (VKTX)

Viking Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-534.8	-359.64	-109.96	-85.9	-68.87	-54.99
Depreciation & Amortization	0.45	0.43	0.35	0.29	0.29	0.3
Other Amortization	0.01	0.06	0.09	0.09	0.06	0.02
Loss (Gain) From Sale of Investments	-6.02	-9.34	-17.38	-8.2	1.22	3.91
Stock-Based Compensation	37.39	40.82	29.71	16.75	8.67	6.1
Other Operating Activities	0.1	0.01	0.04	0.04	0.04	0.01
Change in Accounts Payable	63.52	43.44	2.3	-1.02	7.09	-2.54
Change in Other Net Operating Assets	20.9	5.54	7.06	4.57	3.1	-0.38
Operating Cash Flow	-418.44	-278.69	-87.79	-73.38	-48.4	-47.59
Operating Cash Flow Growth	-	-	-	-	-	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Investment in Securities	399.26	341.39	-553.37	-179.09	54.75	37.96
Investing Cash Flow	399.26	341.39	-553.37	-179.09	54.75	37.96

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Issuance of Common Stock	111.25	76.44	654.57	278.5	12.51	7.63
Repurchase of Common Stock	-	-	-42.1	-7.12	-8.33	-0.71
Other Financing Activities	-	-	-	-	-0.02	-0.05
Financing Cash Flow	111.25	76.44	612.46	271.38	4.16	6.88

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Foreign Exchange Rate Adjustments	0.02	-0.01	-0.15	-0.03	-0.26	-
Net Cash Flow	92.08	139.13	-28.84	18.88	10.26	-2.75

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Levered Free Cash Flow	-230.79	-160.22	-55.58	-42.36	-25.22	-32.16
Unlevered Free Cash Flow	-230.8	-160.24	-55.61	-42.4	-25.24	-32.16

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Change in Working Capital	84.42	48.98	9.36	3.55	10.19	-2.93

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Jul 29, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 16, 2026

Data Sources Report a data error